MedTrace Logo

Pilot Removal of Palpable Subdermal Contraceptive Rod Implants

NCT03356119 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2018-10-18

No results posted yet for this study

Summary

There are no implant removal devices on the market by any manufacturer. Overall, the RemovAid™ combines the features of fixation, incision and extraction. This combination of functions has not previously been combined in a single device.

The investigators wish to perform this pilot clinical investigation with the aim to demonstrate that the Investigational Medical Device (IMD), RemovAid ™, may safely and effectively facilitate implant removal. Other aims are to show that the IMD have the potential to reduce procedure length variability, reduce procedural complexity and reduce the need for additional procedural equipment related to CI removal procedures, without causing any harm to the subject.

Conditions

  • Removal of Contraceptive Implant

Interventions

DEVICE

RemovAid device

The contraceptive implants of the subjects in this arm are removed by the new IMD.

Sponsors & Collaborators

  • Karolinska University Hospital

    collaborator OTHER

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • The Research Council of Norway

    collaborator OTHER

  • Amano Clinical Consulting AB

    collaborator OTHER

  • RemovAid AS

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-12
Primary Completion
2018-05-01
Completion
2018-09-04

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03356119 on ClinicalTrials.gov